Item 8.01. Other Events
Applied Therapeutics, Inc. (the "Company") currently intends to hold its first
Annual Meeting of Stockholders (the "Annual Meeting") on June 4, 2020, at a time
and location to be determined and specified in the Company's proxy statement
related to the Annual Meeting. Under the SEC's rules, stockholders who have
continuously held at least $2,000 in market value, or 1%, of the common stock of
the Company for at least one year by the date they submit the proposal are
eligible to submit a proposal. The Company has set the deadline for submission
of proposals to be included in its proxy materials for the Annual Meeting as of
March 6, 2020. Accordingly, in order for a stockholder proposal to be considered
for inclusion in the Company's proxy materials for the Annual Meeting, the
proposal must be received by the Secretary of the Company at the Company's
offices at 545 5th Avenue, Suite 1400, New York, NY 10017, on or before such
date, and comply with the procedures and requirements set forth in Rule 14a-8
under the Exchange Act.
In accordance with the advance notice requirements contained in the Amended and
Restated Bylaws of the Company (the "Bylaws"), for director nominations or other
business to be brought before the Annual Meeting by a stockholder, other than
Rule 14a-8 proposals described above, written notice must be delivered to the
Secretary of the Company no later than March 6, 2020. These stockholder notices
also must comply with the requirements of the Bylaws and will not be effective
otherwise.
© Edgar Online, source Glimpses